Publications

5891 Results

Operating characteristics of prostate-specific antigen in men with an initial psa level of 3.0 ng/mL or lower

Authors
IM Thompson;DP Ankerst;C Chi;MS Lucia;PJ Goodman;JJ Crowley;HL Parnes;CA Coltman
Journal / Conference
The Journal of the American Medical Association 294(1):66-70
Year
2005
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

CTFG (CCN2) predicts OS and DFS in adult acute lymphoblastic leukemia

Authors
O Sala-Torra;H Gundacker;DL Stirewalt;PA Ladne;EL Pogosova-Agadjanyan;ML Slovak;CL Willman;S Heimfeld;DH Boldt;JP Radich
Journal / Conference
Blood (ASH Annual Meeting Abstracts) 106(11): #336
Year
2005
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9400

An update of a phase II trial of CHOP followed by tositumomab/iodine I-131 tositumomab (Bexxar) for front-line treatment of advanced stage, follicular lymphoma: Southwest Oncology Group Protocol 9911

Authors
OW Press;J Unger;D Maloney;RM Braziel;M LeBlanc;T Grogan;TP Miller;RI Fisher
Journal / Conference
Blood (ASH Annual Meeting Abstracts) 106(11): #352
Year
2005
Research Committee(s)
Lymphoma
Study Number(s)
S9911

Vinorelbine plus cisplatin vs observation in resected non-small-cell lung cancer

Authors
T Winton;R Livingston;D Johnson;J Rigas;M Johnston;C Butts;Y Cormier;G Goss;R Inculet;E Vallieres;W Fry;D Bethune;J Ayoub;K Ding;K Seymour;B Graham;MS Tsao;D Gandara;K Kesler;T Demmy;F Shepherd
Journal / Conference
New England Journal of Medicine 352(25):2589-2597
Year
2005
Research Committee(s)
Lung
Study Number(s)
JBR10

Correlation of target kinase genotype with clinical activity of imatinib mesylate (IM) in patients with matastatic GI Stromal tumors (GISTs) expressing KIT (KIT+)

Authors
MC Heinrich;JS Shoemaker;CL Corless;D Hollis;GD Demetri;MM Bertagnolli;JA Fletcher
Journal / Conference
Proc of the ASCO, JCO 23(16S):3s (#7)
Year
2005
Research Committee(s)
Sarcoma
Study Number(s)
S0033

Very late antigen-4 (VLA-4) expression by AML blasts: correlation of VCAM-1 binding to overall survival

Authors
PS Becker;T Papayannopoulou;KJ Kopecky;AN Hanks;JM Harlan;CL Willman;FR Appelbaum
Journal / Conference
Blood (ASH Annual Meeting Abstracts) 106(11): #2365
Year
2005
Research Committee(s)
Leukemia

New treatment options have changed the survival of patients with follicular lymphoma

Authors
RI Fisher;M LeBlanc;OW Press;DG Maloney;JM Unger;TP Miller
Journal / Conference
Journal of Clinical Oncology 23(33):8447-8452
Year
2005
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7426/7427, SWOG-7713/14, SWOG-8809, S9800, S9911

Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an Intergroup trial of the Eastern Cooperative Oncology Group

Authors
MK Gibson;Y Li;B Murphy;MHA Hussain;RC DeConti;J Ensley;AA Forastiere
Journal / Conference
Journal of Clinical Oncology 23(15):3562-3567
Year
2005
Research Committee(s)
Head and Neck
Study Number(s)
E1395

Gene expression profiling of bulk CD138+ plasma cells in preneoplastic gammopathy/asymptomatic myeloma identifies distinct subsets of patients

Authors
MV Dhodapkar;F Zhan;E Rasmussen;B Burington;B Durie;J Crowley;B Barlogie;J Shaughnessy
Journal / Conference
Blood (ASH Annual Meeting Abstracts) 106(11): #1218
Year
2005
Research Committee(s)
Myeloma
Study Number(s)
S0120

A randomized phase III trial of paclitaxel versus paclitaxel plus bevacizumab as first-line therapy for locally recurrent or metastatic breast cancer: a trial coordinated by the Eastern Cooperative Oncology Group (E2100)

Authors
KD Miller;M Wang;JR Gralow;M Dickler;MA Cobleigh;EA Perez;TN Shenkier;NE Davidson
Journal / Conference
Breast Cancer Research and Treatment 94(Suppl 1):S6(#3)
Year
2005
Research Committee(s)
Breast
Study Number(s)
CTSU/E2100